175 related articles for article (PubMed ID: 31133363)
21. Real-world treatment patterns and outcomes in refractory metastatic colorectal cancer.
Chiang CL; Choi HC; Lam KO; Chan BY; Lee SF; Yeung SY; Lau KS; Chan SY; Choy TS; Yuen KK
Asia Pac J Clin Oncol; 2019 Mar; 15 Suppl 2():5-13. PubMed ID: 30887726
[TBL] [Abstract][Full Text] [Related]
22. PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium.
Bossé D; Mercer J; Raissouni S; Dennis K; Goodwin R; Jiang D; Powell E; Kumar A; Lee-Ying R; Price-Hiller J; Heng DY; Tang PA; MacLean A; Cheung WY; Vickers MM
Clin Colorectal Cancer; 2016 Sep; 15(3):243-9. PubMed ID: 26964803
[TBL] [Abstract][Full Text] [Related]
23. Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms.
Knauf W; Aldaoud A; Hutzschenreuter U; Klausmann M; Dille S; Wetzel N; Jänicke M; Marschner N;
Ann Hematol; 2018 Dec; 97(12):2437-2445. PubMed ID: 30069704
[TBL] [Abstract][Full Text] [Related]
24. Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.
Carlson RW; Tu SW; Lane NM; Lai TL; Kemper CA; Musen MA; Shortliffe EH
Online J Curr Clin Trials; 1995 Mar; Doc No 179():[3347 words; 32 paragraphs]. PubMed ID: 7719564
[TBL] [Abstract][Full Text] [Related]
25. Effect of Reasons for Screen Failure on Subsequent Treatment Outcomes in Cancer Patients Assessed for Clinical Trials.
Tiu C; Loh Z; Gan CL; Gan H; John T; Hawkes E
Oncology; 2019; 97(5):270-276. PubMed ID: 31266008
[TBL] [Abstract][Full Text] [Related]
26. Impact of Duration of Neoadjuvant Radiation on Rectal Cancer Survival: A Real World Multi-center Retrospective Cohort Study.
Abdel-Rahman O; Kumar A; Kennecke HF; Speers CH; Cheung WY
Clin Colorectal Cancer; 2018 Mar; 17(1):e21-e28. PubMed ID: 28709877
[TBL] [Abstract][Full Text] [Related]
27. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.
Jeremias A; Ruisi CP; Kirtane AJ; Lee T; Sylvia B; Pinto DS; Ho KK; Cutlip DE; Carrozza JP; Cohen DJ
Coron Artery Dis; 2008 Mar; 19(2):111-5. PubMed ID: 18300748
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study.
Iizumi S; Shimoi T; Tsushita N; Bun S; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Fujiwara Y; Tamura K
BMC Cancer; 2017 Dec; 17(1):819. PubMed ID: 29202787
[TBL] [Abstract][Full Text] [Related]
29. Racial Disparities in Endometrial Cancer Clinical Trial Representation: Exploring the Role of Eligibility Criteria.
Wolf JL; Hamilton A; An A; Leonard JP; Kanis MJ
Am J Clin Oncol; 2024 May; ():. PubMed ID: 38700907
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.
Shah JJ; Abonour R; Gasparetto C; Hardin JW; Toomey K; Narang M; Srinivasan S; Kitali A; Zafar F; Flick ED; Rifkin RM
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):575-583.e2. PubMed ID: 28886839
[TBL] [Abstract][Full Text] [Related]
31. Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study.
Abdel-Rahman O; Xu Y; Kong S; Dort J; Quan ML; Karim S; Bouchard-Fortier A; Cho H; Cheung WY
Clin Breast Cancer; 2019 Apr; 19(2):e297-e305. PubMed ID: 30630679
[TBL] [Abstract][Full Text] [Related]
32. Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study.
Berden FA; de Knegt RJ; Blokzijl H; Kuiken SD; van Erpecum KJ; Willemse SB; den Hollander J; van Vonderen MG; Friederich P; van Hoek B; van Nieuwkerk CM; Drenth JP; Kievit W
PLoS One; 2016; 11(9):e0161821. PubMed ID: 27598789
[TBL] [Abstract][Full Text] [Related]
33. Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.
Cottin V; Arpin D; Lasset C; Cordier JF; Brune J; Chauvin F; Trillet-Lenoir V
Ann Oncol; 1999 Jul; 10(7):809-15. PubMed ID: 10470428
[TBL] [Abstract][Full Text] [Related]
34. Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis.
Brown N; Melville M; Gray D; Young T; Skene AM; Wilcox RG; Hampton JR
Heart; 1999 Jun; 81(6):598-602. PubMed ID: 10336917
[TBL] [Abstract][Full Text] [Related]
35. Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World Practice.
Mitchell AP; Harrison MR; Walker MS; George DJ; Abernethy AP; Hirsch BR
J Oncol Pract; 2015 Nov; 11(6):491-7. PubMed ID: 26330533
[TBL] [Abstract][Full Text] [Related]
36. Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?
Khurana A; Mwangi R; Nowakowski GS; Habermann TM; Ansell SM; LaPlant BR; Link BK; Cerhan JR; Maurer MJ; Witzig TE
J Clin Oncol; 2021 May; 39(15):1641-1649. PubMed ID: 33529046
[TBL] [Abstract][Full Text] [Related]
37. Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies.
Statler A; Othus M; Erba HP; Chauncey TR; Radich JP; Coutre S; Advani A; Nand S; Ravandi F; Mukherjee S; Sekeres MA
Blood; 2018 Jun; 131(25):2782-2788. PubMed ID: 29618479
[TBL] [Abstract][Full Text] [Related]
38. Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry.
Goebell PJ; Staehler M; Müller L; Nusch A; Scheffler M; Sauer A; von Verschuer U; Tech S; Kruggel L; Jänicke M; Marschner N;
Clin Genitourin Cancer; 2018 Dec; 16(6):e1101-e1115. PubMed ID: 30061035
[TBL] [Abstract][Full Text] [Related]
39. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
Unger JM; Hershman DL; Fleury ME; Vaidya R
JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
[TBL] [Abstract][Full Text] [Related]
40. Evaluating eligibility criteria of oncology trials using real-world data and AI.
Liu R; Rizzo S; Whipple S; Pal N; Pineda AL; Lu M; Arnieri B; Lu Y; Capra W; Copping R; Zou J
Nature; 2021 Apr; 592(7855):629-633. PubMed ID: 33828294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]